ANI Pharmaceuticals, Inc. , a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
Ani Pharmaceuticals stock last closed at $60.51, down 0.41% from the previous day, and has decreased 2.23% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.36 percentage points. Ani Pharmaceuticals stock is currently +25.54% from its 52-week low of $48.20, and -14.55% from its 52-week high of $70.81.
As of Sep 6, 2024, there are 21.04M shares of ANIP outstanding. The market value of ANIP is $1.27B. In the last 24 hours, 409,932 ANIP shares were traded.
How to Buy Ani Pharmaceuticals Stock
Wondering how to invest in Ani Pharmaceuticals stock? Here's how.
Figure out where to buy Ani Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Ani Pharmaceuticals stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Fund your brokerage account: Select your method of payment and add your details.
Analyze Ani Pharmaceuticals stock: The Ani Pharmaceuticals ticker symbol is ANIP. Is Ani Pharmaceuticals stock a good investment? Should you buy shares of ANIP? How do ANIP's underlying business fundamentals look? Do top analysts think Ani Pharmaceuticals is a good buy? Why has ANIP's stock price moved recently? (Hint: Our stock market analysis website can help you understand if ANIP is a good stock to buy).
Execute your ANIP purchase: Decide if you will purchase ANIP shares at the current market price or use a limit order to purchase ANIP stock at a given price.
Keep an eye on your ANIP investment: Create a watchlist to get the latest news on your investment in Ani Pharmaceuticals stock.
Step 1: Figure out where to buy Ani Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy ANIP shares.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global markets: From Technology to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal info so you are able to buy ANIP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Ani Pharmaceuticals stock
After you have chosen the best place to buy Ani Pharmaceuticals stock, it's critical to research their stock before you invest, so you actually understand the risk as well as the opportunity.
Ani Pharmaceuticals stock at a glance
ANIP Price
$60.51
1w %
-5.08%
1y %
-2.23%
5y %
-7.24%
P/E
51.28x
P/B
2.79x
P/S
2.17x
PEG
0.89x
Revenue
$538.95M
Earnings
$25.39M
Fore. Rev. Growth
12.75%
Fore. Earn. Growth
57.56%
Market Cap
$1.27B
Next Earnings
Nov 6, 2024
Next Dividend
N/A
Ani Pharmaceuticals Zen Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
Last year, ANIP earnings were $25.39M. In the past five year, ANIP's earnings have gone up by -4.43% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 11.24%.
Last year, ANIP revenue was $538.95M. During the last 5 year, ANIP's revenue has increased by 20.17% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 19.54%.
No, Ani Pharmaceuticals doesn't provide an income stream by paying out dividends.
ANIP Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your ANIP purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually sufficient.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and eToro will place your order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Ani Pharmaceuticals share?
As of Sep 6, 2024, it costs $60.51 to buy one share of Ani Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.165 shares of ANIP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.